Pancreatic Cancer Research

ResearcherNew York UniversityNo recent work listed

George Miller

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-8482-4100; OpenAlex author ID A5059165900; NIH RePORTER profile ID 9734311. Sources: OpenAlex.

Their work

Papers
28 (first author 6, last author 11)
Trials
0
Grants
5
Labs led
2
Collaborators
79
Papers, trials and grants by year

2012: 1 paper, 1 grant · 2013: 1 paper · 2014: 2 papers, 1 grant · 2015: 2 papers · 2016: 1 paper · 2017: 5 papers · 2018: 3 papers · 2019: 5 papers, 1 grant · 2020: 3 papers · 2021: 1 grant · 2022: 2 papers, 1 grant · 2023: 3 papers

Papers 28

  1. Correction to: BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer. Last author DOI 10.1038/s41388-023-02606-9↗
  2. Reply to: Revisiting the intrinsic mycobiome in pancreatic cancer. Last author DOI 10.1038/s41586-023-06293-0↗
  3. The critical immune basis for differential responses to immunotherapy in primary versus metastatic pancreatic cancer. Last author DOI 10.18632/oncotarget.28373↗
  4. Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer. Co-author DOI 10.1016/j.ccell.2022.05.006↗
  5. BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer. Last author DOI 10.1038/s41388-022-02425-4↗
  6. Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels. Co-author DOI 10.1038/s41388-020-1186-7↗
  7. Regulation and modulation of antitumor immunity in pancreatic cancer. First author DOI 10.1038/s41590-020-0761-y↗
  8. Regulatory T Cells Keep Pancreatic Cancer at Bay. Last author DOI 10.1158/2159-8290.cd-20-0002↗
  9. Harnessing the Microbiome for Pancreatic Cancer Immunotherapy. Last author DOI 10.1016/j.trecan.2019.10.005↗
  10. Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer. Co-author DOI 10.1021/acsmedchemlett.9b00108↗
  11. Microbes as biomarkers and targets in pancreatic cancer. First author DOI 10.1038/s41571-019-0276-3↗
  12. The Role of the Microbiome in Immunologic Development and its Implication For Pancreatic Cancer Immunotherapy. Co-author DOI 10.1053/j.gastro.2018.12.045↗
  13. Upregulation of ZIP14 and Altered Zinc Homeostasis in Muscles in Pancreatic Cancer Cachexia. Co-author DOI 10.3390/cancers12010003↗
  14. RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer. Last author DOI 10.1016/j.ccell.2018.10.006↗
  15. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Co-author DOI 10.1136/gutjnl-2016-312580↗
  16. The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Last author DOI 10.1158/2159-8290.cd-17-1134↗
  17. Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer. Co-author DOI 10.1016/j.celrep.2017.06.062↗
  18. Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer. First author DOI 10.1016/j.molmed.2017.03.003↗
  19. Myeloid-derived suppressor cells and their role in pancreatic cancer. First author DOI 10.1038/cgt.2016.65↗
  20. The role of γδ T cells in pancreatic cancer: what could this mean for the clinic? First author DOI 10.1080/17474124.2017.1312344↗
  21. Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations. Co-author DOI 10.5306/wjco.v8.i3.230↗
  22. TIMPing Fate: Why Pancreatic Cancer Cells Sojourn in the Liver. First author DOI 10.1053/j.gastro.2016.09.035↗
  23. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Co-author DOI 10.1158/0008-5472.can-14-2211↗
  24. TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia. Last author DOI 10.1371/journal.pone.0132786↗
  25. Pancreatic cancer, inflammation, and microbiome. Last author DOI 10.1097/ppo.0000000000000045↗
  26. Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression. Co-author DOI 10.1172/jci72619↗
  27. Induction of TRIF- or MYD88-dependent pathways perturbs cell cycle regulation in pancreatic cancer. Last author DOI 10.4161/cc.24488↗
  28. Effect of intra-operative fluid volume on peri-operative outcomes after pancreaticoduodenectomy for pancreatic adenocarcinoma. Co-author DOI 10.1002/jso.22048↗

Grants 5

  1. Dectin-1 signaling drives pancreatic oncogenesis by inducing macrophage-mediated adaptive immune suppression R01CA215471↗
  2. Regulation of Pancreatic Oncogenesis by the Gut Microbiome R01CA206105↗
  3. Regulation of Pancreatic Oncogenesis by RIP1 Kinase R01CA168611↗
  4. Innovative Grant: George Miller (necroptosis in pancreatic tumorigenesis) AWARD pancan:2014-george-miller-md-innovative-grant-george-miller-necroptos
  5. The Role of Dendritic Cells in Pancreatic Tumorigenesis R21CA155649↗

Closest collaborators

The 25 strongest of 79 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Deirdre Jill Cohen · 5 shared papers, 1 shared grant, 2018–2023 · strength 0.91
  2. Dafna Bar‐Sagi · 3 shared papers, 1 shared grant, 2015–2022 · strength 0.77
  3. Joshua Leinwand · 5 shared papers, 2018–2023 · strength 0.73
  4. Deepak Saxena · 3 shared papers, 1 shared grant, 2014–2021 · strength 0.68
  5. Brian E. Diskin · 4 shared papers, 2018–2023 · strength 0.60
  6. Berk Aykut · 5 shared papers, 2018–2023 · strength 0.53
  7. Kwok Kin Wong · 1 shared grant, 2022 · strength 0.52
  8. Diane M. Simeone · 1 shared grant, 2021 · strength 0.44
  9. Smruti Pushalkar · 3 shared papers, 2014–2023 · strength 0.38
  10. Constantinos Pantelis Zambirinis · 4 shared papers, 2014–2018 · strength 0.30
  11. Gregor Werba · 3 shared papers, 2018–2023 · strength 0.29
  12. Wei Wang · 3 shared papers, 2018–2023 · strength 0.29
  13. Gerardo A. Vitiello · 2 shared papers, 2019 · strength 0.28
  14. Fangxi Xu · 1 shared paper, 2023 · strength 0.26
  15. Deepak Saxena · 1 shared paper, 2023 · strength 0.26
  16. Donnele Daley · 3 shared papers, 2015–2018 · strength 0.24
  17. Emma Kurz · 3 shared papers, 2018–2022 · strength 0.22
  18. Alejandro Torres-Hernandez · 3 shared papers, 2015–2018 · strength 0.21
  19. Matthew Pergamo · 1 shared paper, 2017 · strength 0.15
  20. Atsuo Ochi · 3 shared papers, 2013–2018 · strength 0.13
  21. Vrishketan Sethi · 1 shared paper, 2019 · strength 0.12
  22. Vikas Dudeja · 1 shared paper, 2019 · strength 0.12
  23. An Ngo‐Huang · 1 shared paper, 2022 · strength 0.12
  24. Nathan H. Parker · 1 shared paper, 2022 · strength 0.12
  25. Keri Schadler · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.